Evidence map›Paper›PMID 40352502›Full record

ArticleACS omega2025

Downregulation of MGAT3 Promotes Benzo[

Su Zhang, Xia-Yan Zhang, Xiao-Chun Zheng, Xiao-Lan Ye, Ping Huang, Wen-Tong Liu, Hong-Juan Jiang

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Su ZhangCenter for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Shangtang Road No. 158, Hangzhou 310014, Zhejiang, China.
Xia-Yan ZhangDepartment of Pharmacy, the Fifth Affiliated Hospital of Wenzhou Medical University, Kuocang Road No. 289, Lishui 323000, Zhejiang, China.
Xiao-Chun ZhengCenter for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Shangtang Road No. 158, Hangzhou 310014, Zhejiang, China.
Xiao-Lan YeCenter for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Shangtang Road No. 158, Hangzhou 310014, Zhejiang, China.
Ping HuangCenter for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Shangtang Road No. 158, Hangzhou 310014, Zhejiang, China.
Wen-Tong LiuSchool of Pharmacy, Hangzhou Normal University, Binwen Road No. 481, Hangzhou 311121, Zhejiang, China.
Hong-Juan JiangCenter for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Shangtang Road No. 158, Hangzhou 310014, Zhejiang, China.ORCID https://orcid.org/0000-0002-6083-0730

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental chemical carcinogens are major factors in the induction of lung cancer, with benzo[

Identifiers

PMID40352502
PMCPMC12060035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.